{"id":"NCT01922258","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type","officialTitle":"A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Flexible Dosing of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09","primaryCompletion":"2017-03","completion":"2017-03","firstPosted":"2013-08-14","resultsPosted":"2020-07-07","lastUpdate":"2020-11-20"},"enrollment":270,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Agitation Associated With","Alzheimer's Disease","Alzheimer's Type","Mental Disorder","Nervous System Diseases"],"interventions":[{"type":"DRUG","name":"Brexpiprazole, OPC-34712","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Brexpiprazole (flexible dose range 0.5 to 2 mg)","type":"EXPERIMENTAL"}],"summary":"To compare the efficacy of flexible dosing of brexpiprazole with placebo in subjects with agitation associated with dementia of the Alzheimer's type","primaryOutcome":{"measure":"Change From Baseline to Week 12/Early Termination in the Cohen-Mansfield Agitation Inventory (CMAI) Total Score","timeFrame":"From screening to week 12/early termination","effectByArm":[{"arm":"Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day)","deltaMin":-18.9,"sd":1.17},{"arm":"Placebo (Flexible Dose Range 0.5 to 2 mg/Day)","deltaMin":-16.5,"sd":1.13}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.1454"}]},"eligibility":{"minAge":"55 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":8},"locations":{"siteCount":70,"countries":["United States","Bulgaria","Canada","Finland","France","Russia","Slovenia","Ukraine","United Kingdom"]},"refs":{"pmids":["40681915","39108660","31708380"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":132},"commonTop":["Headache","Somnolence","Dizziness"]}}